Design, synthesis, and SAR of cis-1,2-diaminocyclohexane derivatives as potent factor Xa inhibitors. Part II: Exploration of 6-6 fused rings as alternative S1 moieties

被引:32
作者
Yoshikawa, Kenji [1 ]
Kobayashi, Shozo [2 ]
Nakamoto, Yumi [2 ]
Haginoya, Noriyasu [1 ]
Komoriya, Satoshi [2 ]
Yoshino, Toshiharu [1 ]
Nagata, Tsutomu [2 ]
Mochizuki, Akiyoshi [2 ]
Watanabe, Kengo [2 ]
Suzuki, Makoto [1 ]
Kanno, Hideyuki [3 ]
Ohta, Toshiharu [1 ]
机构
[1] Daiichi Sankyo Co Ltd, R&D Div, Edogawa Ku, Tokyo 1348630, Japan
[2] Daiichi Sankyo Co Ltd, R&D Div, Shinagawa Ku, Tokyo 1408710, Japan
[3] Daiichi Sankyo RD Associe Co Ltd, Edogawa Ku, Tokyo 1348630, Japan
关键词
Anticoagulant; Factor Xa inhibitor; Solubility; Food effect; DISCOVERY; CHEMISTRY; ESTERS;
D O I
10.1016/j.bmc.2009.10.024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of cis-1,2-diaminocyclohexane derivatives possessing a 6-6 fused ring for the S1 moiety were synthesized as novel factor Xa (fXa) inhibitors. The synthesis, structure-activity relationship (SAR), and physicochemical properties are reported herein, together with the discovery of compound 45c, which has potent anti-fXa activity, good physicochemical properties and pharmacokinetic (PK) profiles, including a reduced negative food effect. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:8221 / 8233
页数:13
相关论文
共 33 条
[1]   Crystal structures of two potent nonamidine inhibitors bound to factor Xa [J].
Adler, M ;
Kochanny, MJ ;
Ye, B ;
Rumennik, G ;
Light, DR ;
Biancalana, S ;
Whitlow, M .
BIOCHEMISTRY, 2002, 41 (52) :15514-15523
[2]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[3]   The Baylis-Hillman reaction: A novel carbon-carbon bond forming reaction [J].
Basavaiah, D ;
Rao, PD ;
Hyma, RS .
TETRAHEDRON, 1996, 52 (24) :8001-8062
[4]   Concise synthesis of stereodefined, thiazole -: containing cyclic hexa- and octapeptide relatives of the Lissoclinums, via cyclooligomerisation reactions [J].
Bertram, A ;
Blake, AJ ;
de Turiso, FGL ;
Hannam, JS ;
Jolliffe, KA ;
Pattenden, G ;
Skae, M .
TETRAHEDRON, 2003, 59 (35) :6979-6990
[5]   Progress in the discovery of Factor Xa inhibitors [J].
Casimiro-Garcia, A ;
Dudley, DA ;
Heemstra, RJ ;
Filipski, KJ ;
Bigge, CF ;
Edmunds, JJ .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (02) :119-145
[6]   Factor Xa inhibitors:: S1 binding interactions of a series of N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}sulfonamides [J].
Chan, Chuen ;
Borthwick, Alan D. ;
Brown, David ;
Burns-Kurtis, Cynthia L. ;
Campbell, Matthew ;
Chaudry, Laiq ;
Chung, Chun-wa ;
Convery, Maire A. ;
Hamblin, J. Nicole ;
Johnstone, Lisa ;
Kelly, Henry A. ;
Kleanthous, Savvas ;
Patikis, Angela ;
Patel, Champa ;
Pateman, Anthony J. ;
Senger, Stefan ;
Shah, Gita P. ;
Toomey, John R. ;
Watson, Nigel S. ;
Weston, Helen E. ;
Whitworth, Caroline ;
Young, Robert J. ;
Zhou, Ping .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (07) :1546-1557
[7]  
Desai Sapan S, 2006, Recent Pat Cardiovasc Drug Discov, V1, P307, DOI 10.2174/157489006778777016
[8]   Novel anticoagulants and the future of anticoagulation [J].
Garcia, David .
THROMBOSIS RESEARCH, 2009, 123 :S50-S55
[9]   Synthesis and conformational analysis of a non-amidine factor Xa inhibitor that incorporates 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine as S4 binding element [J].
Haginoya, N ;
Kobayashi, S ;
Komoriya, S ;
Yoshino, T ;
Suzuki, M ;
Shimada, T ;
Watanabe, K ;
Hirokawa, Y ;
Furugori, T ;
Nagahara, T .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (21) :5167-5182
[10]   Facile methods for preparation of thiazolopyridine and tetrahydrothiazolopyridine derivatives [J].
Haginoya, N ;
Komoriya, S ;
Osanai, K ;
Yoshino, T ;
Nagata, T ;
Nagamochi, M ;
Muto, R ;
Yamaguchi, M ;
Nagahara, T ;
Kanno, H .
HETEROCYCLES, 2004, 63 (07) :1555-1561